Bullying Perpetration and Narcissistic Personality Traits across Adolescence: Joint Trajectories and Childhood Risk Factors

von Farrell, Ann H., Vaillancourt, Tracy
Veröffentlicht in Front Psychiatry (2020)

Flexibility and innovation in the FDA’s novel regulatory approval strategies for hematologic drugs

von Farrell, Ann T., Goldberg, Kirsten B., Pazdur, Richard
Veröffentlicht in Blood (2017)

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events

von Gupta, Harsh V, Farrell, Ann M, Mittal, Manoj K
Veröffentlicht 2014

Effects of daily iron supplementation in primary-school–aged children: systematic review and meta-analysis of randomized controlled trials

von Low, Michael, Farrell, Ann, Biggs, Beverley-Ann, Pasricha, Sant-Rayn
Veröffentlicht 2013

Carbapenem Resistant Enterobacteriaceae and Endoscopy: An Evolving Threat

von O'Horo, John C., Farrell, Ann, Sohail, M. Rizwan, Safdar, Nasia
Veröffentlicht in Am J Infect Control (2016)

Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care

von Bohra, Anuj, Worland, Thomas, Hui, Samuel, Terbah, Ryma, Farrell, Ann, Robertson, Marcus
Veröffentlicht in World J Gastroenterol (2020)

The NOURISH randomised control trial: Positive feeding practices and food preferences in early childhood - a primary prevention program for childhood obesity

von Daniels, Lynne A, Magarey, Anthea, Battistutta, Diana, Nicholson, Jan M, Farrell, Ann, Davidson, Geoffrey, Cleghorn, Geoffrey
Veröffentlicht 2009

Systematic Review with Meta-analysis: Recurrence of Crohn's disease after Total Colectomy with Permanent Ileostomy

von Fumery, Mathurin, Dulai, Parambir S., Meirick, Paul, Farrell, Ann M., Ramamoorthy, Sonia, Sandborn, William J., Singh, Siddharth
Veröffentlicht in Aliment Pharmacol Ther (2016)

FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma

von Kasamon, Yvette L., de Claro, R. Angelo, Wang, Yaping, Shen, Yuan Li, Farrell, Ann T., Pazdur, Richard
Veröffentlicht in Oncologist (2017)

An appraisal of published usability evaluations of electronic health records via systematic review

von Ellsworth, Marc A, Dziadzko, Mikhail, O'Horo, John C, Farrell, Ann M, Zhang, Jiajie, Herasevich, Vitaly
Veröffentlicht in J Am Med Inform Assoc (2017)

Effects of Toxic Compounds in Montipora capitata on Exogenous and Endogenous Zooxanthellae Performance and Fertilization Success

von Hagedorn, Mary, Farrell, Ann, Carter, Virginia, Zuchowicz, Nikolas, Johnston, Erika, Padilla-Gamiño, Jacqueline, Gunasekera, Sarath, Paul, Valerie
Veröffentlicht in PLoS One (2015)

Survival of ethnic and racial minority patients with multiple myeloma treated with newer medications

von Pulte, E. Dianne, Nie, Lei, Gormley, Nicole, Goldberg, Kirsten B., McKee, Amy, Farrell, Ann, Pazdur, Richard
Veröffentlicht in Blood Adv (2018)

FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

von Pulte, Elizabeth Dianne, Dmytrijuk, Andrew, Nie, Lei, Goldberg, Kirsten B., McKee, Amy E., Farrell, Ann T., Pazdur, Richard
Veröffentlicht in Oncologist (2018)

FDA Approval Summary: Temsirolimus as Treatment for Advanced Renal Cell Carcinoma

von Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Mitchell, Shan Sun, Sridhara, Rajeshwari, Pazdur, Richard
Veröffentlicht 2010

In Reply

von Kwitkowski, Virginia E., Prowell, Tatiana M., Ibrahim, Amna, Farrell, Ann T., Justice, Robert, Sun Mitchell, Shan, Sridhara, Rajeshwari, Pazdur, Richard
Veröffentlicht 2010

FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33‐Positive Acute Myeloid Leukemia

von Norsworthy, Kelly J., Ko, Chia‐Wen, Lee, Jee Eun, Liu, Jiang, John, Christy S., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Veröffentlicht in Oncologist (2018)

U.S. Food and Drug Administration Benefit‐Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Re...

von Pulte, E. Dianne, Wroblewski, Tanya, Bloomquist, Erik, Tang, Shenghui, Farrell, Ann, Deisseroth, Albert, McKee, Amy E., Pazdur, Richard
Veröffentlicht in Oncologist (2019)

FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell‐Induced Severe or Life‐Threatening Cytokine Release Syndrome

von Le, Robert Q., Li, Liang, Yuan, Weishi, Shord, Stacy S., Nie, Lei, Habtemariam, Bahru A., Przepiorka, Donna, Farrell, Ann T., Pazdur, Richard
Veröffentlicht in Oncologist (2018)

FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B‐Cell Acute Lymphoblastic Leukemia

von Pulte, E. Dianne, Vallejo, Jonathon, Przepiorka, Donna, Nie, Lei, Farrell, Ann T., Goldberg, Kirsten B., McKee, Amy E., Pazdur, Richard
Veröffentlicht in Oncologist (2018)

A Benefit-Risk Analysis Approach to Capture Regulatory Decision-Making: Multiple Myeloma

von Raju, G.K., Gurumurthi, Karthik, Domike, Reuben, Kazandjian, Dickran, Landgren, Ola, Blumenthal, Gideon M., Farrell, Ann, Pazdur, Richard, Woodcock, Janet
Veröffentlicht in Clin Pharmacol Ther (2017)